Xavier Preville

Title: Xavier Preville: Innovator in Oncolytic Virus Therapy

Introduction

Xavier Preville is a notable inventor based in Saint Louis, France. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the combination of oncolytic viruses with immune checkpoint modulators, which has the potential to revolutionize cancer therapies.

Latest Patents

Xavier Preville holds a patent for a groundbreaking invention titled "Combination of Oncolytic Virus with Immune Checkpoint Modulators." This patent provides a combination comprising at least an oncolytic virus and one or more immune checkpoint modulators for the treatment of proliferative diseases such as cancer. The invention also includes a kit that contains an oncolytic virus and immune checkpoint modulators in separate containers, as well as a pharmaceutical composition comprising effective amounts of both components. He has 1 patent to his name.

Career Highlights

Throughout his career, Xavier Preville has worked with prestigious organizations, including the Institut Gustave Roussy and Transgene S.A. His experience in these institutions has allowed him to collaborate with leading experts in the field of oncology and immunotherapy.

Collaborations

Xavier has collaborated with notable colleagues such as Laurence Zitvogel and Laetitia Fend. Their combined expertise has contributed to advancements in cancer treatment and research.

Conclusion

Xavier Preville is a pioneering inventor whose work in oncolytic virus therapy holds promise for the future of cancer treatment. His innovative approach and dedication to research continue to inspire advancements in the medical field.